Stemming the tide of stem cell scams
In April 2019, the Federal Trade Commission returned almost $515,000 to consumers who bought deceptively marketed “amniotic stem cell therapy” between 2014 and 2017.
That came after the agency found that osteopath Dr. Bryn Jarald Henderson and the companies he owns and operates, Regenerative Medical Group and Telehealth Medical Group, deceptively advertised that their amniotic stem cell therapy could treat serious diseases, including Parkinson’s disease, autism, macular degeneration, cerebral palsy, multiple sclerosis and heart disease.
A Drop in the Bucket Across the country and around the world, the proliferation of unproven cellular therapies is a $2 billion business, according to a recent paper in Cytotherapy, co-authored by an impressive international team of stem cell experts who were at a symposium for the International Society for Cellular Therapies in 2018.